Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 20 Prostatic Neoplasms 19 Carcinoma, Hepatocellular 15 Brain Neoplasms 12 Breast Neoplasms 10 Pancreatic Neoplasms 9 Neoplasm Metastasis 9 Lung Neoplasms 5 Neoplasms 4 Recurrence 3 Colorectal Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neuroma, Acoustic 2 NSCLC 2 Liver Neoplasms 2 Head and Neck Neoplasms 2 Glioblastoma 2 Esophageal Neoplasms 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer 1 Stage IA - IB Non Small Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Spine Metastasis 1 Spinal Neoplasms 1 Spinal Bone Metastases 1 Solid Tumor 1 Sarcoma 1 Rare Diseases 1 Radiotherapy 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Radiotherapy × Radiosurgery × Clear all

NCT03963713 2019-07-19

SCIRSM

Peking University Third Hospital

Phase NA Unknown

Radiotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡